Full Text View
Tabular View
No Study Results Posted
Related Studies
Ixabepilone to Treat Cervical Cancer
This study is currently recruiting participants.
Verified March 2013 by National Institutes of Health Clinical Center (CC)
Study NCT00924066   Information provided by National Institutes of Health Clinical Center (CC)

First Received on June 17, 2009.   Last Updated on May 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cervical Carcinoma
Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Additional conditions recognized in this trial
Adenocarcinoma
Adenocarcinoma, Mucinous
Carcinoma
Carcinoma, Adenosquamous
Uterine Cervical Neoplasms
More general conditions related to this trial
Genital Diseases, Female
Genital Neoplasms, Female
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Complex and Mixed
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Urogenital Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Uterine Neoplasms
Interventions listed in this trial
Ixempra (Ixbepilone (BMS-247550) )
Additional drug interventions recognized in this trial
Epothilones
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services